psalexa
SearchBar Icon

Order Summary & Billing Information

Order Summary
GO BACK TO REPORT PAGE
Report Title

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

License

Single User License

Price

$4700

Billing Information

Clicking Proceed to Secure Checkout means that you agree to the P&S Intelligence's terms & conditions.